News About Expanesthetics

Expanesthetics Hires Chief Scientific Officer, Dr. Peter Wright

July 1, 2016

Expanesthetics continues to expand its management team with the hiring this month of part-time Chief Scientific Officer Dr. Peter Wright. Dr. Wright has a PhD in Pharmacokinetics, is a former Professor of Anesthesia at the University of California, San Francisco and has been practicing anesthesia for over 25 years. He will be leading Expanesthetics' research efforts as both the anesthetic and analgesic programs continue to advance through preclinical studies. Please join us in welcoming Dr. Wright to the Expanesthetics family!

Back to top

Expanesthetics Crosses $1M Funding Milestone

February 7, 2016 | Davis Enterprise

The Davis Enterprise, Expanesthetics' home town newspaper, reported the achievement of an important fundraising milestone. In 2012, Mark Holman met Robert Brosnan at an entrepreneurship academy at the local university campus. Robert had come to learn about building new companies on a foundation of innovative technology and Mark was serving as a mentor to the many faculty members and students.

Back to top

Expanesthetics Spotlighted by Leading Research University

February 2, 2016 | Child Family Institute for Innovation and Entrepreneurship

Founded in 2012, Expanesthetics is tackling one of the longest-standing scientific questions in modern medicine: How do general anesthetics work? The company's goal is to expand the choice of anesthetic agents available for clinical use in order to improve patient outcomes and reduce costs. This story tells some of Expanesthetics' history and progress to-date.

Back to top

Expanesthetics Sponsors 54th Clinical Conference in Pediatric Anesthesiology

February 1, 2016

Expanesthetics returns this month to sponsor and exhibit at the 54th Clinical Conference in Pediatric Anesthesiology in Anaheim, California. Because inhalation anesthesia plays a particularly important role in the pediatric setting, Expanesthetics is actively seeking to develop a new and improved inhalation general anesthetic to address the unique challenges in pediatric anesthesia. Expanesthetics' CEO, Mark Holman, feels that the feedback received from pediatric clinicians at this event make it a very important piece of the company’s strategy to serve all segments of the anesthesia community.

Back to top

Expanesthetics Exhibits at PGA 2015 in New York

December 31, 2015

Expanesthetics exhibited this month at the PostGraduate Assembly in Anesthesiology in New York, sponsored by the New York State Society of Anesthesiologists. Following on the success of a pilot survey conducted at this year's ASA conference, Expanesthetics conducted a follow-on survey with attendees of the PGA conference to gather opinions around the future of inhalation anesthesia and what characteristics are desirable in a new inhalation anesthetic. Please contact us directly if you are interested in the results of this clinical feasibility survey.

Back to top